How to Import Medicines into Indonesia for Personal Use for Cancer, Chronic and Rare Diseases - A 2026 Guide

Summary - This guide is for patients in Indonesia who are considering sourcing a prescription medicine from abroad for their own treatment. It breaks down what Indonesian regulations say about importing medicines for personal use, which conditions apply, what paperwork is involved and what customs apply. You will also learn how MedsPartner can help you explore access to quality-assured generic, biosimilar, or equivalent medicines for cancer, rare disease, HIV, hepatitis, autoimmune, cardiology & other conditions via compliant personal importation, facilitated for eligible patients.

Indonesia runs one of the largest single-payer health insurance programmes in the world. The Jaminan Kesehatan Nasional (JKN), administered by BPJS Kesehatan, had more than 284 million registered participants as of July 2026. For most Indonesians, JKN is the first point of contact for hospital care, specialist referrals & prescribed medicines listed on the national formulary.

However, broad enrollment has not removed the cost burden altogether. According to the Ministry of Health's national health accounts published in 2026 - total health spending reached Rp 639.9 trillion in 2024, and out-of-pocket payments still made up 28.3% of it. The International Bar Association's 2025 healthcare survey notes that patients continue to pay directly for treatments and medicines that fall outside JKN or private insurance coverage.

Cancer care shows these gaps clearly. A 2025 study on JKN implementation reported that hospitals are reimbursed at fixed rates for expensive medicines such as chemotherapy, often below what the medicines cost to procure. In practice, a newer therapy may be off the formulary, out of stock at the treating hospital, or priced beyond what a family can manage privately.

When that happens, patients in Indonesia may explore importing a medicine for personal use, subject to local regulations, eligibility criteria and documentation requirements.

When Do Patients in Indonesia Consider Personal Importation of Medicines?

Personal importation here means arranging a prescription medicine from a source outside Indonesia, solely for your own treatment.

Indonesian patients usually explore this option for a handful of reasons. A medicine approved abroad may not yet hold a marketing authorisation from BPOM - so no local pharmacy can stock it. It may be registered but missing from the national formulary, which means JKN will not cover its cost. Supply at the treating hospital may be irregular. Or the private price may simply be out of reach over a long treatment course, even for patients who also hold private insurance.

MedsPartner helps eligible patients faced by these hurdles explore personal importation of affordable, quality-assured medicines as per Indonesian regulations, with step-by-step guidance throughout the process.

What Makes Generics and Biosimilars Sourced With The Help of MedsPartner Less Expensive than Locally Available Medicines?

Patients comparing prices often find that an international generic or biosimilar version of their prescribed medicine costs far less than the branded product at a local pharmacy. The gap comes from the cost and manufacturing structure behind each product.

An originator company carries the full expense of discovering a drug, running clinical trials across several phases, and securing regulatory approval in multiple markets. That investment often spans more than a decade. Generic and biosimilar manufacturers enter the market after patent protection ends. They do not repeat the discovery work, so their pricing reflects the cost of making the medicine rather than the cost of inventing it. This means lower prices for customers.

Before a generic or biosimilar can be authorised as a substitute for an originator product, regulators ask for bioequivalence or comparability data. This evidence shows that the medicine performs in the body in a comparable way to the original.

Furthermore, the generic, biosimilar and equivalent medicine manufacturing facilities MedsPartner works with hold approvals from one or more of the USFDA, EMA, PIC/S, WHO-GMP and other international regulatory bodies. Getting these approvals involves stringent on-site inspections, quality systems audits, and continued compliance oversight. Hence, these quality and regulatory checks provide assurance regarding the manufacturing standards, quality systems, and traceability of the medicines.

Because of these reasons, quality-assured generics, biosimilars and equivalent medicines can offer similar therapeutic effects at a lower price tag.

How Do Indonesian Regulations Treat Medicines Imported for Personal Use?

Indonesian regulations provide mechanisms for individuals to import medicines for personal use, subject to applicable requirements.

The framework is set out in BPOM Regulation Number 27 of 2022 (amended by Regulation 28/2023) on Importation Control of Food and Drugs into the Territory of Indonesia. It lists personal or individual use among the specific purposes for which medicines without an Indonesian marketing authorisation may be imported into the country. Such imports are expected to be in limited quantities based on need, not for sale, and may arrive through courier, cargo, or postal services.

The same regulation states that a prescription medicine imported for personal use should be backed by a doctor's prescription or a hospital recommendation. 

BPOM is the medicines regulator, working alongside the Ministry of Health (Kementerian Kesehatan). Checks on personal-use shipments at the border are carried out by the Directorate General of Customs and Excise (Direktorat Jenderal Bea dan Cukai). 

Who Can Import a Medicine Into Indonesia for Personal Treatment?

Patients facing access or affordability barriers may explore importing medicines for personal use, subject to applicable regulations. This may include people living with cancer, rare diseases, or chronic conditions, as well as those whose prescribed medicine may not be on the national formulary, may not be covered by their insurance, or may not be accessible locally.

A valid prescription is necessary for all personal imports of prescription medicines into Indonesia and the medicine must be for the patient's own treatment only. MedsPartner can offer more detailed guidance regarding the specific regulations for a certain medicine.

Which Treatment Categories Can Indonesian Patients Explore Through MedsPartner?

Patients may explore personal importation of prescription medicines across several therapeutic areas - subject to applicable requirements. These include oncology, rare disease, HIV, hepatitis, autoimmune and inflammatory conditions such as rheumatoid arthritis, cardiology, multiple sclerosis, and others.

MedsPartner helps patients explore access to quality-assured generic, biosimilar, and equivalent options across these areas, subject to applicable personal importation regulations.

Which Medicines Are Restricted for Importing into Indonesia?

Some medicines may be restricted or excluded from personal importation.

• Medicines prohibited under Indonesian law

• Medicines where the applicable BPOM or customs requirements have not been met

If you are unsure where your medicine stands, BPOM or the MedsPartner team can help clarify before you place an order request.

What Are the Warning Signs of a Fake or Substandard Medicine?

BPOM has issued public alerts on counterfeit medicines found in circulation, so a few simple checks are worthwhile -

• Buy only from sources you can verify, and that can tell you where the medicine was manufactured.
• Look at the packaging and labelling when it arrives. The medicine name, strength, batch number, expiry date, and manufacturer details should all be printed clearly.
• Avoid marketplace sellers and social media accounts that do not ask for a prescription or cannot share manufacturer details.

What Is the Quantity Limit for Personal Imports of Medicines into Indonesia?

Under BPOM Regulation - prescription medicines imported for personal use are limited to the amount stated on the doctor's prescription, up to a maximum of 90 days of treatment. MedsPartner can guide you regarding suitable quantities for specific medicines.

Which Documents Are Needed for a Personal Medicine Import to Indonesia?

Valid prescription is required for all personal imports of prescription medicines. Depending on the medicine, other documents may be required, for which MedsPartner will provide guidance.

What Does the Ordering Process With MedsPartner Look Like?

Step 1 - Visit the MedsPartner website and locate the medicine you need.

Step 2 - Place an order request and submit your prescription. No payment is needed at this point.

Step 3 - Our team examines your prescription and checks your eligibility for personal importation within 1-2 working days.

Step 4 - If you are eligible for personal importation, our team will explain the next steps including any additional documents needed, payment mechanisms, and shipping.

Step 5 - Once we receive the payment, your medicine is dispatched within 48 hours, and you will receive tracking information for your shipment. Most deliveries to Indonesia take 7-10 days.

For anything else, write to support@medspartner.com.

What Happens When My Imported Medicine Reaches Indonesian Customs?

Medicines arriving by courier or post are examined by the Directorate General of Customs and Excise, which may coordinate with BPOM where needed. Customs assesses shipments based on factors including their nature, quantity, and applicable requirements. Clearance may depend on the specific medicine, documentation, and other specific circumstances. The status of an incoming parcel can be followed through the DJBC consignment tracking page.

Any duties or taxes that apply are separate from MedsPartner's pricing and are paid to the relevant authority or carrier. Duties are charged as per the total shipment value, and we can provide you an estimate of the applicable charges. We may also provide guidance regarding the customs process.

Patient Experience - Accessing a Cancer Medicine in Surabaya, Indonesia

Bobby*, a 59-year-old retired teacher in Surabaya, was diagnosed with advanced lung cancer. His oncologist recommended a targeted therapy for lung cancer as the next step in his treatment. The medicine was not available to him through JKN, and the private price quoted by the hospital pharmacy was more than the family could pay for on their own.

His daughter, who works in Jakarta, began researching options online and came across MedsPartner. After the family submitted Bobby's prescription and medical documents, our team checked his eligibility and supported him through the personal importation process. A quality-assured generic alternative was delivered to Surabaya from an Indian FDA-approved facility within nine days.

*Name changed for privacy

Frequently Asked Questions About Importing Medicines for Personal Use in Indonesia

Q1. Is it legal to import a medicine for personal use in Indonesia?

A - Indonesian regulations provide mechanisms for individuals to import medicines for personal use, subject to applicable criteria. BPOM Regulation Number 27 of 2022 includes personal use among the purposes for which medicines may be imported, based on a prescription or hospital recommendation and in limited quantities. Write to support@medspartner.com for guidance on your specific medicine.

Q2. What documents do I need to import a medicine to Indonesia?

A - A valid prescription is essential for importing prescription medicines into Indonesia. Depending on the medicine, other documents may be required, for which MedsPartner can provide guidance.

Q3. How long does delivery from MedsPartner take to Indonesia?

A - Most shipments to major cities in Indonesia such as Jakarta, Surabaya, Bandung, and Medan arrive within 7-10 business days from dispatch. You will receive tracking details once the order is shipped through a trusted international courier.

Q4. Do I have to pay duties or taxes on imported medicines in Indonesia?

A - Any applicable duties or taxes are charged as per the total shipment value and are paid to the relevant authority or carrier, separate from MedsPartner's pricing. We can provide an estimate of the applicable charges for your shipment.

Q5. What if JKN does not cover my medicine or the private price is too high?

A - You can first explore the support available locally. The BPJS Kesehatan Care Center 165 can answer questions about your JKN coverage and benefits. The Yayasan Kanker Indonesia (YKI) DKI Jakarta offers early detection services and support for cancer patients and their families. If treatment is still not accessible after exploring these options, you may explore importing medicines for personal use - subject to Indonesian regulations. Write to support@medspartner.com with your prescription and medicine name, and our team can explain the documentation and sourcing process and identify any requirements.

Q6. How much can I save by importing through MedsPartner?

A - Savings vary by medicine and country. International generic, biosimilar, and equivalent options can be substantially less expensive than local branded medicines in some cases, offering up to 70-90% savings. You can check indicative prices on the MedsPartner website.

Q7. Why should I trust MedsPartner for my medicines?

A - Our team has over nine years of experience supporting patients across more than 45 countries. MedsPartner holds a 4.8-star rating on Trustpilot based on reviews from several patients. We help patients source their medicines from manufacturing facilities holding approvals from the USFDA, EMA, PIC/S, WHO-GMP or equivalent regulatory bodies, via compliant personal importation. These quality and regulatory checks provide assurance regarding the manufacturing standards, quality systems, and traceability of the medicines.

Q8. How do I get started with MedsPartner?

A - Find your medicine on the MedsPartner website and send an order request along with your prescription. No payment is needed at this stage. Our team reviews your documents and checks your eligibility. Once payment is made, your medicine is dispatched within 48 hours with tracking details. Write to support@medspartner.com if you need help at any point.

Q9. How much medicine can I import at one time?

A - BPOM rules limit personal imports of prescription medicines to the quantity on your doctor's prescription, up to a maximum of 90 days of treatment. Our team can help you plan order quantities in line with your prescription.

Q10. What happens if customs holds my shipment?

A - Shipments are usually held if the medicine is banned, the quantity is too high, or the documents are incomplete. MedsPartner only ships medicines that are permitted for personal importation and in quantities consistent with personal use. In the rare scenario that a shipment is still held by customs, we can provide further guidance on a case-to-case basis.

Q11. Can refrigerated or biological medicines be shipped to Indonesia?

A - Cold-chain shipping of medicines to Indonesia may be available for certain medicines. Contact support@medspartner.com to discuss your specific medicine and requirements before placing an order.

 

Useful Links for Patients in Indonesia:

• BPOM - Badan Pengawas Obat dan Makanan
• Ministry of Health (Kementerian Kesehatan)
• Directorate General of Customs and Excise (Bea dan Cukai)
• BPJS Kesehatan
• Yayasan Kanker Indonesia (YKI) DKI Jakarta

Still have questions about sourcing a medicine for personal use in Indonesia? Write to support@medspartner.com and our team can explain the sourcing and documentation process.

This guide is for informational purposes only and does not constitute legal or medical advice. Indonesian import regulations are subject to change - always verify current requirements with BPOM or a qualified healthcare professional before proceeding. Please consult your physician for all treatment decisions.

About the Author - Atul Goyal works on the operational side of cross-border medicine access, where logistics, pricing, and regulatory requirements meet. At MedsPartner, he oversees how international medicine shipments are planned and delivered, with a focus on keeping each step compliant and affordable for patients. His background in pharmaceutical supply chains and regulatory frameworks helps him understand the practical hurdles patients face when a treatment is not accessible at home.